Y, D., V, S., MF, d. C., R, H., & D, H. (2025). Safety and effectiveness of immune checkpoint inhibitors in patients with preexisting autoimmune diseases: A systematic review. Frontiers in immunology, 16, 1712632. https://doi.org/10.3389/fimmu.2025.1712632
Chicago Style (17th ed.) CitationY, Dias, Silva V, de Carvalho MF, Herchenhorn R, and Herchenhorn D. "Safety and Effectiveness of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Diseases: A Systematic Review." Frontiers in Immunology 16 (2025): 1712632. https://doi.org/10.3389/fimmu.2025.1712632.
MLA (9th ed.) CitationY, Dias, et al. "Safety and Effectiveness of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Diseases: A Systematic Review." Frontiers in Immunology, vol. 16, 2025, p. 1712632, https://doi.org/10.3389/fimmu.2025.1712632.